182 related articles for article (PubMed ID: 6791000)
1. Treatment of heroin-dependent persons with antagonists: current status.
Renault PF
NIDA Res Monogr; 1981; 28():11-22. PubMed ID: 6791000
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of naltrexone treatment of opiate-dependent individuals. Report of the National Research Council Committee on Clinical Evaluation of Narcotic Antagonists.
Arch Gen Psychiatry; 1978 Mar; 35(3):335-40. PubMed ID: 365122
[TBL] [Abstract][Full Text] [Related]
3. Naltrexone implants can completely prevent early (1-month) relapse after opiate detoxification: a pilot study of two cohorts totalling 101 patients with a note on naltrexone blood levels.
Foster J; Brewer C; Steele T
Addict Biol; 2003 Jun; 8(2):211-7. PubMed ID: 12850780
[TBL] [Abstract][Full Text] [Related]
4. Naltrexone for heroin dependence treatment in St. Petersburg, Russia.
Krupitsky EM; Zvartau EE; Masalov DV; Tsoi MV; Burakov AM; Egorova VY; Didenko TY; Romanova TN; Ivanova EB; Bespalov AY; Verbitskaya EV; Neznanov NG; Grinenko AY; O'Brien CP; Woody GE
J Subst Abuse Treat; 2004 Jun; 26(4):285-94. PubMed ID: 15182893
[TBL] [Abstract][Full Text] [Related]
5. A comparison of mental health hospital admissions in a cohort of heroin users prior to and after rapid opiate detoxification and oral naltrexone maintenance.
Arnold-Reed DE; O'Neil P; Holman CD; Bulsara MK; Rodiguez C; Gawthorne G; Tait RJ; Hulse GK
Am J Drug Alcohol Abuse; 2007; 33(5):655-64. PubMed ID: 17891658
[TBL] [Abstract][Full Text] [Related]
6. Treatment of heroin-dependent persons with antagonists: current status.
Renault PF
Bull Narc; 1978; 30(2):21-9. PubMed ID: 252920
[No Abstract] [Full Text] [Related]
7. Naltrexone for opioid dependence. An additional tool for general practitioners.
Tedeschi M
Aust Fam Physician; 2002 Jan; 31(1):18-20. PubMed ID: 11840882
[TBL] [Abstract][Full Text] [Related]
8. Naltrexone implants as treatment for heroin dependence: part I.
Byrne A; Graham G; Hallinan R; Murnion B
Addict Biol; 2005 Jun; 10(2):201; author reply 201-2. PubMed ID: 16191674
[No Abstract] [Full Text] [Related]
9. A pilot study to assess the impact of naltrexone implant on accidental opiate overdose in 'high-risk' adolescent heroin users.
Hulse GK; Tait RJ
Addict Biol; 2003 Sep; 8(3):337-42. PubMed ID: 13129836
[TBL] [Abstract][Full Text] [Related]
10. Naltrexone for probationers and parolees.
O'Brien C; Cornish JW
J Subst Abuse Treat; 2006 Sep; 31(2):107-11. PubMed ID: 16919734
[TBL] [Abstract][Full Text] [Related]
11. Behavioral therapy to augment oral naltrexone for opioid dependence: a ceiling on effectiveness?
Nunes EV; Rothenberg JL; Sullivan MA; Carpenter KM; Kleber HD
Am J Drug Alcohol Abuse; 2006; 32(4):503-17. PubMed ID: 17127538
[TBL] [Abstract][Full Text] [Related]
12. Judicially mandated naltrexone use by criminal offenders: a legal analysis.
Bonnie RJ
J Subst Abuse Treat; 2006 Sep; 31(2):121-7. PubMed ID: 16919737
[TBL] [Abstract][Full Text] [Related]
13. Naltrexone as a "mandate" or as a choice comments on "Judicially mandated naltrexone use by criminal offenders: a legal analysis".
Presenza LJ
J Subst Abuse Treat; 2006 Sep; 31(2):129-30. PubMed ID: 16919738
[No Abstract] [Full Text] [Related]
14. What you need to know: addiction--prescribing naltrexone.
Yeo BK
Singapore Med J; 1997 Feb; 38(2):92-3. PubMed ID: 9269372
[TBL] [Abstract][Full Text] [Related]
15. Short-term effects of naltrexone in 155 heroin ex-addicts.
Volavka J; Resnick RB; Kestenbaum RS; Freedman AM
Biol Psychiatry; 1976 Dec; 11(6):679-85. PubMed ID: 999987
[TBL] [Abstract][Full Text] [Related]
16. Naltrexone with or without fluoxetine for preventing relapse to heroin addiction in St. Petersburg, Russia.
Krupitsky EM; Zvartau EE; Masalov DV; Tsoy MV; Burakov AM; Egorova VY; Didenko TY; Romanova TN; Ivanova EB; Bespalov AY; Verbitskaya EV; Neznanov NG; Grinenko AY; O'Brien CP; Woody GE
J Subst Abuse Treat; 2006 Dec; 31(4):319-28. PubMed ID: 17084785
[TBL] [Abstract][Full Text] [Related]
17. Narcotic antagonists. Treatment tool for addiction.
Valentine NM; Meyer RE
Nurs Clin North Am; 1976 Sep; 11(3):541-9. PubMed ID: 785400
[TBL] [Abstract][Full Text] [Related]
18. Naltrexone: a clinical perspective.
Greenstein RA; Arndt IC; McLellan AT; O'Brien CP; Evans B
J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):25-8. PubMed ID: 6469933
[TBL] [Abstract][Full Text] [Related]
19. [Surprising conclusion by the SBU concerning the benefits of naltrexone in the treatment of heroin dependence].
Heilig M
Lakartidningen; 2002 Jan; 99(3):200-4. PubMed ID: 11838078
[No Abstract] [Full Text] [Related]
20. Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone.
Hulse GK; Morris N; Arnold-Reed D; Tait RJ
Arch Gen Psychiatry; 2009 Oct; 66(10):1108-15. PubMed ID: 19805701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
